These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32455343)
41. PD-1 blockade augments humoral immunity through ICOS-mediated CD4 Zhang M; Xia L; Yang Y; Liu S; Ji P; Wang S; Chen Y; Liu Z; Zhang Y; Lu S; Wang Y Int Immunopharmacol; 2019 Jan; 66():127-138. PubMed ID: 30448635 [TBL] [Abstract][Full Text] [Related]
42. Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis. Wang B; Bai W; Ma H; Li F Med Sci Monit; 2021 Jan; 27():e927577. PubMed ID: 33386384 [TBL] [Abstract][Full Text] [Related]
43. Investigation of Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485 [TBL] [Abstract][Full Text] [Related]
44. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
45. ICOS contributes to T cell expansion in CTLA-4 deficient mice. van Berkel ME; Schrijver EH; Hofhuis FM; Sharpe AH; Coyle AJ; Broeren CP; Tesselaar K; Oosterwegel MA J Immunol; 2005 Jul; 175(1):182-8. PubMed ID: 15972646 [TBL] [Abstract][Full Text] [Related]
46. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353 [TBL] [Abstract][Full Text] [Related]
48. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity. Wong SC; Tan AH; Lam KP Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753 [TBL] [Abstract][Full Text] [Related]
50. [Association of ICOS and CD28 single nucleotide polymorphisms with pulmonary tuberculosis susceptibility]. Zhang X; Ji JM; Li Q; Hua TQ; Yao P; Jiang JY; Li SS; Wang FM Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(44):3466-3470. PubMed ID: 31826563 [No Abstract] [Full Text] [Related]
51. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664 [TBL] [Abstract][Full Text] [Related]
52. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii. Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399 [TBL] [Abstract][Full Text] [Related]
53. Critical role of activation-inducible lymphocyte immunomediatory molecule/inducible costimulator in the effector function of human T cells: a comparative in vitro study of effects of its blockade and CD28 blockade in human beings and monkeys. Tajima N; Tezuka K; Tanaka M; Tanimoto M; Miyai A; Takeshima H; Watanabe Y Hum Immunol; 2008 Jul; 69(7):399-408. PubMed ID: 18638655 [TBL] [Abstract][Full Text] [Related]
54. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800 [TBL] [Abstract][Full Text] [Related]
56. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134 [TBL] [Abstract][Full Text] [Related]
57. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]
58. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Paulos CM; Carpenito C; Plesa G; Suhoski MM; Varela-Rohena A; Golovina TN; Carroll RG; Riley JL; June CH Sci Transl Med; 2010 Oct; 2(55):55ra78. PubMed ID: 20980695 [TBL] [Abstract][Full Text] [Related]
59. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Cunninghame Graham DS; Wong AK; McHugh NJ; Whittaker JC; Vyse TJ Hum Mol Genet; 2006 Nov; 15(21):3195-205. PubMed ID: 17000707 [TBL] [Abstract][Full Text] [Related]